THBD and COVID-19: These unexpected observations in the CAT assay may be attributed to elevated plasma levels of anticoagulant factors, such as thrombomodulin (TM) – a tissue factor pathway inhibitor (TFPI), existing in certain COVID-19 patients, as shown by published data (41, 42, 68, 70).